Statin Use in Relation to COVID-19 and Other Respiratory Infections: Muscle and Other Considerations
Open Access
- 13 July 2023
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (14) , 4659
Abstract
Statins have been widely advocated for use in COVID-19 based on large favorable observational associations buttressed by theoretical expected benefits. However, past favorable associations of statins to pre-COVID-19 infection outcomes (also buttressed by theoretical benefits) were unsupported in meta-analysis of RCTs, RR = 1.00. Initial RCTs in COVID-19 appear to follow this trajectory. Healthy-user/tolerator effects and indication bias may explain these disparities. Moreover, cholesterol drops in proportion to infection severity, so less severely affected individuals may be selected for statin use, contributing to apparent favorable statin associations to outcomes. Cholesterol transports fat-soluble antioxidants and immune-protective vitamins. Statins impair mitochondrial function in those most reliant on coenzyme Q10 (a mevalonate pathway product also transported on cholesterol)—i.e., those with existing mitochondrial compromise, whom data suggest bear increased risks from both COVID-19 and from statins. Thus, statin risks of adverse outcomes are amplified in those patients at risk of poor COVID-19 outcomes—i.e., those in whom adjunctive statin therapy may most likely be given. High reported rates of rhabdomyolysis in hospitalized COVID-19 patients underscore the notion that statin-related risks as well as benefits must be considered. Advocacy for statins in COVID-19 should be suspended pending clear evidence of RCT benefits, with careful attention to risk modifiers.Keywords
Funding Information
- National Institutes of Health (RO1 HL63055-05)
This publication has 220 references indexed in Scilit:
- The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trialsBMC Medicine, 2013
- Statins and Pulmonary Fibrosis: The Potential Role of NLRP3 Inflammasome ActivationAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Exertional dyspnea in mitochondrial myopathy: clinical features and physiological mechanismsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Effects of Testosterone on Muscle Strength, Physical Function, Body Composition, and Quality of Life in Intermediate-Frail and Frail Elderly Men: A Randomized, Double-Blind, Placebo-Controlled StudyThe Journal of Clinical Endocrinology & Metabolism, 2010
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsThe Lancet, 2010
- Improvement in sleep apnoea associated with switch from simvastatin to pravastatin: Figure 12009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP productionArthritis & Rheumatism, 2008
- Statins and outcomes in patients with pneumoniaBMJ, 2006
- Atorvastatin Decreases the Coenzyme Q10 Level in the Blood of Patients at Risk for Cardiovascular Disease and StrokeArchives of Neurology, 2004